These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27040338)

  • 41. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmaceuticals and medical devices: medical devices.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
    [No Abstract]   [Full Text] [Related]  

  • 43. Evidence-based medicine and drug-eluting stents.
    O'Dwyer J
    Med Device Technol; 2004 May; 15(4):34-7. PubMed ID: 15303564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmaceuticals and medical devices: medical devices. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217916
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
    Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
    J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical devices; ear, nose, and throat devices; classification of the transcutaneous air conduction hearing aid system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Nov; 67(216):67789-90. PubMed ID: 12422884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How are drugs approved? Part 1: the evolution of the Food and Drug Administration.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2008 Jan; 46(1):15-9. PubMed ID: 18251347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical devices; obstetrical and gynecological devices; classification of the breast lesion documentation system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jul; 68(144):44413-5. PubMed ID: 12884877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons from innovation in drug-device combination products.
    Couto DS; Perez-Breva L; Saraiva P; Cooney CL
    Adv Drug Deliv Rev; 2012 Jan; 64(1):69-77. PubMed ID: 22200650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
    Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
    BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomedical innovation: a risky business at risk.
    Stack RS; Harrington RA
    Sci Transl Med; 2011 Aug; 3(96):96cm23. PubMed ID: 21849662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical devices; reclassification of three anesthesiology preamendments class III devices into class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57366-8. PubMed ID: 11776278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs.
    Golish SR
    Trials; 2017 Jul; 18(1):348. PubMed ID: 28738891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanical devices and US Food and Drug Administration (FDA) approval.
    Reitz BA
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2006; ():123-7. PubMed ID: 16638557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDA regulation of invasive neural recording electrodes: a daunting task for medical innovators.
    Welle C; Krauthamer V
    IEEE Pulse; 2012 Mar; 3(2):37-41. PubMed ID: 22481744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current PMDA Activities for Use of Biomarkers in Drug Evaluation].
    Ishiguro A
    Yakugaku Zasshi; 2015; 135(5):681-4. PubMed ID: 25948301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drugs and other product choices.
    Hyman PM; Carvajal R
    Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.